Published on February 15, 2018
The research and development of medicine for chronic lymphocytic leukemia (CLL) is expensive, but can the cost of a drug deter your path to CLL treatment? How can CLL patients afford therapies long-term? CLL expert Dr. Jeff Sharman from The US Oncology Network discusses the effects of cost on cancer care and decision-making. Nora Larson, from Compass Oncology, also touches on the importance of accepting assistance on your treatment journey and shares resources for financial support.
Provided by CLL Global Research Foundation, which received support from AbbVie Inc., Gilead Sciences, TG Therapeutics, Pharmacyclics LLC and Janssen Biotech, Inc., and Genentech. Produced by Patient Power in collaboration with The US Oncology Network, Compass Oncology, and Willamette Valley Cancer Institute and Research Center.